98%
921
2 minutes
20
The anergic period is defined as a period of around 3-6 weeks following a systemic allergic reaction when skin test results are negative. Therefore, most guidelines recommend that physicians should conduct skin test 6 weeks after an immediate hypersensitivity reaction. However, in vitro tests, including serum-specific immunoglobulin E (IgE) measurement, are generally deemed unaffected by the anergic period. Here, we present a case of a patient with initial cefaclor-specific IgE negativity, but when tested immediately after confirmed anaphylaxis to cefaclor, the results converted to positive after the resolution of the anergic period, 8 weeks post reaction. In patients with a strong clinical suspicion of drug-induced anaphylaxis, repeating in vitro tests after the anergic period may be warranted, even if the initial results are negative. Further investigation is needed to assess whether ImmunoCAP values, similar to skin test reactivity, exhibit significant short-term variability.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.15586/aei.v53i4.1329 | DOI Listing |
Allergol Immunopathol (Madr)
July 2025
Division of Allergy, Asthma and Clinical Immunology, Department of Internal Medicine, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, South Korea;
The anergic period is defined as a period of around 3-6 weeks following a systemic allergic reaction when skin test results are negative. Therefore, most guidelines recommend that physicians should conduct skin test 6 weeks after an immediate hypersensitivity reaction. However, in vitro tests, including serum-specific immunoglobulin E (IgE) measurement, are generally deemed unaffected by the anergic period.
View Article and Find Full Text PDFImmun Ageing
September 2023
Epidemiology, Medical Faculty, University of Augsburg, Augsburg, Germany.
Front Immunol
December 2021
Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany.
T cell anergy is a common mechanism of T cell tolerance. However, although anergic T cells are retained for longer time periods in their hosts, they remain functionally passive. Here, we describe the induction of anergic CD4 T cells by intravenous application of high doses of antigen and their subsequent conversion into suppressive Foxp3 IL-10 Tr1 cells but not Foxp3 Tregs.
View Article and Find Full Text PDFJ Investig Allergol Clin Immunol
April 2022
Division of Clinical Immunology, Department of Pathology, Queen Mary Hospital, Hong Kong.
Cell Rep
February 2021
Institute for Immunology, Biomedical Center, Medical Faculty, Ludwig-Maximilians-Universität München, 82152 Planegg-Martinsried, Germany. Electronic address:
Exhausted immune responses to chronic diseases represent a major challenge to global health. We study CD4 T cells in a mouse model with regulatable antigen presentation. When the cells are driven through the effector phase and are then exposed to different levels of persistent antigen, they lose their T helper 1 (Th1) functions, upregulate exhaustion markers, resemble naturally anergic cells, and modulate their MAPK, mTORC1, and Ca/calcineurin signaling pathways with increasing dose and time.
View Article and Find Full Text PDF